Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Diagnostic accuracy of the 1,3-β-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: A retrospective study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. In vitro activity of 23 tea extractions and epigallocatechin gallate against Candida species

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Diagnostic PCR tests for Microsporum audouinii, M. canis and Trichophyton infections

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Would you like to purchase a rodent with dermatophytes?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pediatric Candidemia Epidemiology and Morbidities: A Nationwide Cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Antibiotic prescribing in paediatric inpatients in Ghana: a multi-centre point prevalence survey

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

1,3-β-D-glucan (BG), a cell-wall component of most fungi including Pneumocystis (PC), is recommended by international guidelines for screening for pneumocystis pneumonia (PCP) in hematologic patients. We retrospectively validated the BG test in our tertiary university hospital. Forty-five patients (median age 53 years, 33% female) tested for PC by polymerase chain reaction (PCR) and/or immunoflourescence (IF)-microscopy with a stored blood sample within ±5 days of the PC test were tested by the Fungitell (cutoff <60 and >80 pg/ml). Cases had symptoms and radiology compatible with PCP and positive IF-microscopy (proven PCP, n = 8) or positive PCR (probable PCP, n = 10). Controls had no compatible symptoms/radiology and negative tests for PC on conventional testing (no PCP, n = 24), or positive PCR/IF-microscopy (colonized, n = 3). Median BG-levels were 1108 pg/ml (proven PCP), 612 pg/ml (probable PCP), 29 pg/ml (colonized), and 48 pg/ml (controls, P < 0.001). Compared to the PCP case/control classification, the BG test showed sensitivities of 83-89% and specificities of 64-74%, positive likelihood ratio (LR) of 3.2 and negative LR of 0.23 at recommended cutoff and moderate agreement between tests. Optimal cutoff was ≥73 pg/ml. In PCR-positive cases, the agreement between the BG test and IF-microscopy was 78-89% with fair/moderate agreement. Elevated BG levels were seen in controls with probable invasive fungal infections (n = 4), hemodialysis, bacterial infections and/or betalactams. To conclude, 11% of patients with PCP would be missed if the BG test had been used for diagnosing PCP. Specificity was moderate. Among PCR-positive patients, the BG test identified more cases than IF-microscopy. BG testing is potentially helpful but sensitivity is insufficient to exclude PCP.

OriginalsprogEngelsk
TidsskriftMedical Mycology
Vol/bind57
Udgave nummer6
Sider (fra-til)710-717
Antal sider7
ISSN1369-3786
DOI
StatusUdgivet - aug. 2019

ID: 55880935